Niramol Savaraj
Hematology & Oncology · Miami, FLNPI 1982654141
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $437 and has fallen 75.1% since, to $109 in 2025. That places this record below the midpoint for hematology & oncology clinicians in FL, where the typical reported total is $3,884.
Across 13 payments — averaging $88.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$174
- Immunocore Limited$144
- Merck$125
- E.r. Squibb & Sons, L.L.C.$125
- Sun Pharmaceutical Industries Inc.$125
- Regeneron Healthcare Solutions, Inc.$119
- plus $341 from 5 others
Across 102 payments — averaging $3758.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$151K
- Exelixis Inc.$142K
- Regeneron$91K
What the payments were for
- Food & beverage$1,152100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 1 | $174 |
| Immunocore Limited | 1 | $144 |
| Merck | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Sun Pharmaceutical Industries Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $119 |
| Iovance Biotherapeutics, Inc. | 1 | $109 |
| Pfizer | 1 | $104 |
| Lilly USA, LLC | 2 | $88 |
| Bristol Myers Squibb | 2 | $28 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,152 in reported general payments places this provider in the 30th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Miami
- Steven FeinMiami$1M
- Srikanth NagallaMiami$639K
- Neil NagovskiMiami$530K
- Carl LandgrenMiami$517K
- Raja MudadMiami$422K
- George NahasMiami$364K
- Fernando de ZarragaMiami$333K
- Mikkael SekeresMiami$278K
- Krishna KomanduriMiami$187K
- Estelamari RodriguezMiami$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.